Literature DB >> 30770636

Molecular epidemiology of acute HCV infection in HIV-positive patients from Hong Kong, Taipei, Tokyo.

Hsin-Yun Sun1, Haruka Uemura2, Ngai-Sze Wong3, Denise P-C Chan3, Bonnie C-K Wong4, Pi-Han Lin5, Li-Hsin Su5, Chien-Ching Hung1,6, Shinichi Oka2, Sui-Yuan Chang5,7, Shui-Shan Lee3.   

Abstract

BACKGROUND: Acute hepatitis C virus (HCV) infections have been increasingly reported among human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) in the Asia-Pacific region. It remains unknown whether international network of HCV transmission has occurred in this region.
METHODS: HIV-positive patients with acute HCV infection, defined as HCV seroconversion within a year or documented acute hepatitis with seroconversion, diagnosed in Hong Kong, Taipei and Tokyo during 2010-2016 were included in this molecular epidemiology study. The NS5B region of the HCV genome (365 bp) was amplified using nested polymerase chain reaction and sequenced.
RESULTS: Of 234 HIV-positive patients with acute HCV infection, all were male with 94% being MSM. At the diagnosis of acute HCV infection, 73.5% had concurrent sexually transmitted diseases and 88.0% were receiving combination antiretroviral therapy. The most prevalent HCV genotype was 3a, 2a and 1b in Hong Kong, Taipei and Tokyo respectively. Nine independent clusters belonging to five genotypes (1b, 2a, 2c, 3a and 6a) were identified, each of which occurred in one city without overlapping except for one 3a sequence from Taipei that was closely related genetically to the Hong Kong cluster.
CONCLUSIONS: No international network of HCV transmission was identified among HIV-positive patients in the three Asia-Pacific cities. The transmission dynamics of sexually acquired HCV differed by city, but the risk of intercity clustering should not be ignored.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Asia-Pacific; chemsex; direct acting antivirals; male-to-male sex; sexually transmitted infection

Year:  2019        PMID: 30770636     DOI: 10.1111/liv.14073

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

1.  Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study.

Authors:  Bo-Huang Liou; Hsin-Yun Sun; Chia-Jui Yang; Ling-Shan Syue; Yu-Lin Lee; Hung-Jen Tang; Hung-Chin Tsai; Chi-Ying Lin; Tun-Chieh Chen; Chun-Yuan Lee; Sung-Hsi Huang; Chia-Wei Liu; Po-Liang Lu; Shih-Ping Lin; Ning-Chi Wang; Aristine Cheng; Wen-Chien Ko; Shu-Hsing Cheng; Chien-Ching Hung
Journal:  Infect Dis Ther       Date:  2021-03-18

2.  Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018.

Authors:  Shu-Yuan Ho; Li-Hsin Su; Hsin-Yun Sun; Yu-Shan Huang; Yu-Chung Chuang; Miao-Hui Huang; Wen-Chun Liu; Yi-Ching Su; Pi-Han Lin; Sui-Yuan Chang; Chien-Ching Hung
Journal:  EClinicalMedicine       Date:  2020-06-27

Review 3.  Review on the molecular epidemiology of sexually acquired hepatitis C virus infection in the Asia-Pacific region.

Authors:  Chin Pok Chan; Haruka Uemura; Tsz Ho Kwan; Ngai Sze Wong; Shinichi Oka; Denise Pui Chung Chan; Shui Shan Lee
Journal:  J Int AIDS Soc       Date:  2020-09       Impact factor: 5.396

4.  Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand.

Authors:  Supanat Thitipatarakorn; Tanat Chinbunchorn; Jitsupa Peelay; Pich Seekaew; Sorawit Amatavete; Monsiri Sangsai; Tippawan Pankam; Anchalee Avihingsanon; Matthew Avery; Praphan Phanuphak; Reshmie Ramautarsing; Nittaya Phanuphak
Journal:  BMC Public Health       Date:  2022-01-20       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.